Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NEK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NEK6 - Colchicine anti-inflammatory effect: time course and dose response
NEK6 - Monocytes and macrophages (RNG/MRC)
NEK6 - Monocyte-derived macrophage response to decoy receptor 3
NEK6 - Epidermal stem cell and transit-amplifying cell (HG-U133B)
NEK6 - Cystic fibrosis pathology and 4-phenylbutyrate (HG-U133B)
NEK6 - Acute myeloid leukemia cell lines with high Ecotropic Viral Integration site 1 expression
NEK6 - CXC chemokine ligand 4 effect on monocyte-derived macrophages
NEK6 - Chlamydia pneumonia infection effect on dendritic cells
NEK6 - Monocytes and macrophages (Affymetrix)
NEK6 - Clear cell renal cell carcinoma (HB-U133B)
NEK6 - Gliomas of grades III and IV (HG-U133B)
NEK6 - High-grade gliomas (HG-U133B)
NEK6 - Valproic acid effect on theca cells (HG-U133B)
NEK6 - Renal clear cell carcinoma (HG-U133B)
NEK6 - Interleukin 17A effect on monocyte-derived dendritic cells
NEK6 - Zinc finger transcription factor ZXDC depletion effect on myeloid cell line undergoing differentiation
NEK6 - Ribavirin effect on uninfected hepatoma Huh7.5.1 cells
NEK6 - Late passage LNCaP prostate tumor cells treated with androgen receptor shRNA or androgen R1881
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on